Effects of topiramate on smoking in patients with schizoaffective disorder, bipolar type
- PMID: 18344743
- PMCID: PMC3675443
- DOI: 10.1097/JCP.0b013e31816740cf
Effects of topiramate on smoking in patients with schizoaffective disorder, bipolar type
Comment in
-
Topiramate for smoking cessation and the importance to distinguish withdrawal-motivated consumption and cue-triggered automatisms.J Clin Psychopharmacol. 2009 Apr;29(2):192-3; author reply 193-4. doi: 10.1097/JCP.0b013e31819a6c81. J Clin Psychopharmacol. 2009. PMID: 19512990 No abstract available.
References
-
- Johnson BA. Recent advances in the development of treatments for alcohol and cocaine dependence: Focus on topiramate and other modulators of gaba or glutamate function. CNS Drugs. 2005;19:873–896. - PubMed
-
- Johnson BA, Ait-Daoud N, Bowden CL, et al. Oral topiramate for treatment of alcohol dependence: A randomized controlled trial. Lancet. 2003;361:1677–1685. - PubMed
-
- Johnson BA, Ait-Daoud N, Akhtar FZ, et al. Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers. Arch Intern Med. 2005;165:1600–1605. - PubMed
-
- Khazaal Y, Cornuz J, Bilancioni R, et al. Topiramate for smoking cessation. Psychiatry and Clinical Neurosciences. 2006;60:384–388. - PubMed
-
- Anthenelli RM, Blom TJ, McElroy SL, et al. A double-blind, placebo-controlled trial of topiramate as an aid to smoking cessation. Poster presented at: 12th Annual Meeting of the Society for Research on Nicotine and Tobacco; February 15–18, 2006; Orlando, Florida.
